Benzinga - Thu, 08 Apr 2021 05:01:56 -0400
Benzinga - Wed, 07 Apr 2021 13:04:30 -0400
Benzinga - Wed, 07 Apr 2021 08:12:41 -0400
Sector: Health Care.Industry: Biotechnology
Vyant Bio Inc is a vital new force in drug discovery. Its AnalytiX platform, at the intersection of human biology and machine learning, is unmatched in its ability to analyze robust functional data to identify drug candidates. Its proprietary microOrgan technology uses functional microtissues engineered from induced pluripotent stem cells (iPSC) to facilitate high-throughput, human-based drug discovery without the risks or delayed timing of testing drugs in humans.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-07-09
REV
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-04-23
REV

Related Companies

TickerCompanyChg %Mkt Cap
VYNTVyant Bio-7.71%

Vyant Bio Company Questions & Answers

Q

How do I buy Vyant Bio (VYNT) stock?

A

You can purchase shares of Vyant Bio (NASDAQ: VYNT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Vyant Bio's (VYNT) main competitors?

A

Other companies in Vyant Bio’s space includes: Neurocrine Biosciences (NASDAQ:NBIX), CureVac (NASDAQ:CVAC) and Amgen (NASDAQ:AMGN).

Q

What is the target price for Vyant Bio?

A

There is no analysis for Vyant Bio

Q

How much is Vyant Bio (VYNT) stock ?

A

The stock price for Vyant Bio (NASDAQ: VYNT) is $3.71 last updated Mon Apr 12 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Vyant Bio (VYNT) dividend?

A

There are no upcoming dividends for Vyant Bio.

Q

When is Vyant Bio (NASDAQ:VYNT) reporting earnings?

A
Vyant Bio’s Q2 earnings are confirmed from now on July 9, 2021.
Q

When is the upcoming split for VYNT?

A

There is no upcoming split for Vyant Bio.